BRIEF-Mayne Pharma updates on FDA approval and first generic launch of Acticlate tablets

Mayne Pharma Group Ltd:

* FDA approval and first generic launch of acticlate tablets

* U.S. FDA granted approval of ANDA for doxycycline hyclate immediate release (IR) tablets (75 MG AND 150 MG) in United States

* Mayne Pharma has immediately commenced commercial launch to customers in U.S. Source text for Eikon: Further company coverage:

'); $('.second-article-divide').append($('.slider.slider-module')); $('.third-article-divide').append(''); var median = (relatedItemsTotal / 2); var $relatedContentGroupOne = $('.related-content.group-one ul'); var $relatedContentGroupTwo = $('.related-content.group-two ul'); $.each($relatedItems, function(k,v) { if (k + 1 Also In Healthcare
Source: BRIEF-Mayne Pharma updates on FDA approval and first generic launch of Acticlate tablets